Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum

Background: Pathogenic variants of the lysine acetyltransferase 6A or KAT6A gene are associated with a newly identified neurodevelopmental disorder characterized mainly by intellectual disability of variable severity and speech delay, hypotonia, and heart and eye malformations. Although loss of func...

Descripción completa

Detalles Bibliográficos
Autores: Urreizti, Roser, López Martín, Estrella, Martínez Monseny, Antonio Federico, Pujadas, Montserrat, Castilla-Vallmanya, Laura, Pérez Jurado, Luis Alberto, Serrano, Mercedes L., Natera de Benito, Daniel, Martínez Delgado, Beatriz, Posada de la Paz, Manuel, Alonso, Javier, Marín Reina, Purificación, O'Callaghan, Mar, Grinberg, Daniel, Bermejo Sánchez, Eva, Balcells, Susana
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:España
Institución:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/44304
Acceso en línea:http://hdl.handle.net/10230/44304
http://dx.doi.org/10.1186/s13023-020-1317-9
Access Level:acceso abierto
Palabra clave:Clinical characterization
Clinical genetics
KAT6A
Neurodevelopmental disease
Whole exome sequencing
Descripción
Sumario:Background: Pathogenic variants of the lysine acetyltransferase 6A or KAT6A gene are associated with a newly identified neurodevelopmental disorder characterized mainly by intellectual disability of variable severity and speech delay, hypotonia, and heart and eye malformations. Although loss of function (LoF) mutations were initially reported as causing this disorder, missense mutations, to date always involving serine residues, have recently been associated with a form of the disorder without cardiac involvement. Results: In this study we present five new patients, four with truncating mutations and one with a missense change and the only one not presenting with cardiac anomalies. The missense change [p.(Gly359Ser)], also predicted to affect splicing by in silico tools, was functionally tested in the patient’s lymphocyte RNA revealing a splicing effect for this allele that would lead to a frameshift and premature truncation. Conclusions: An extensive revision of the clinical features of these five patients revealed high concordance with the 80 cases previously reported, including developmental delay with speech delay, feeding difficulties, hypotonia, a high bulbous nose, and recurrent infections. Other features present in some of these five patients, such as cryptorchidism in males, syndactyly, and trigonocephaly, expand the clinical spectrum of this syndrome.